Literature DB >> 16557905

Seroepidemiological and ecological studies of the adenovirus-associated satellite viruses.

W P Parks1, D W Boucher, J L Melnick, L H Taber, M D Yow.   

Abstract

The seroepidemiology of the defective adenovirus-associated satellite viruses was studied by use of a neutralization test that has been shown to be much more sensitive than the complement-fixation (CF) test. Less than 25% of the subjects in any age group were positive for any type of satellite virus CF antibody. The neutralization test revealed serological evidence of satellite infection in almost 80% of the subjects in some age groups. Studies of geometric mean antibody titers by neutralization showed that antibody against type 1 and the type 2-3 complex reached peak levels at 2 to 3 years of age; antibody against types 2 and 3 reached mean titers of 500 to 800, whereas mean antibody levels of only 200 were found for type 1. Type 4 antibodies were rarely noted in human sera. In a companion study in monkeys, monospecific responses to types 1 and 4 were found only in rhesus and green monkey sera, respectively. These data suggest that the type 2-3 complex may be the only naturally occurring satellite serotype which infects man and that antibodies noted against types 1 and 4 may be the result of cross-reactions. No satellite viruses were isolated from throat or rectal swabs of 100 children between 6 months and 3 years of age. However, the patterns of adenovirus and enterovirus isolations from these specimens were typical of previous studies in this laboratory.

Entities:  

Year:  1970        PMID: 16557905      PMCID: PMC416080          DOI: 10.1128/iai.2.6.716-722.1970

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  EVALUATION OF COMMUNITY VACCINATION AGAINST POLIOMYELITIS IN HOUSTON, TEXAS, 1962.

Authors:  J L MELNICK; W P PARKS
Journal:  Am J Hyg       Date:  1964-09

2.  ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES.

Authors:  R W ATCHISON; B C CASTO; W M HAMMON
Journal:  Science       Date:  1965-08-13       Impact factor: 47.728

3.  COMMUNITY INFECTION WITH ST. LOUIS ENCEPHALITIS VIRUS. SEROLOGIC STUDY OF THE 1964 EPIDEMIC IN HOUSTON.

Authors:  C A PHILLIPS; J L MELNICK
Journal:  JAMA       Date:  1965-07-19       Impact factor: 56.272

4.  Association of 20-Millimicron Particles with Adenoviruses.

Authors:  J L Melnick; H D Mayor; K O Smith; F Rapp
Journal:  J Bacteriol       Date:  1965-07       Impact factor: 3.490

5.  The association of viruses and bacteria with infantile diarrhea.

Authors:  M D Yow; J L Melnick; R J Blattner; W B Stephenson; N M Robinson; M A Burkhardt
Journal:  Am J Epidemiol       Date:  1970-07       Impact factor: 4.897

6.  Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics.

Authors:  M D Hoggan; N R Blacklow; W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1966-06       Impact factor: 11.205

7.  Physical assay and growth cycle studies of a defective adeno-satellite virus.

Authors:  W P Parks; J L Melnick; R Rongey; H D Mayor
Journal:  J Virol       Date:  1967-02       Impact factor: 5.103

8.  Failure of a replicating adenovirus to enhance adeno-associated satellite virus replication.

Authors:  D W Boucher; W P Parks; J L Melnick
Journal:  Virology       Date:  1969-12       Impact factor: 3.616

9.  Properties of a small virus associated with adenovirus type 4.

Authors:  K O Smith; W D Gehle; J F Thiel
Journal:  J Immunol       Date:  1966-12       Impact factor: 5.422

10.  Complement-fixing antibodies to type 2 (Lansing) poliomyelitis virus in a normal population of a subtropical area.

Authors:  N GOLDBLUM; J L MELNICK
Journal:  J Exp Med       Date:  1952-08       Impact factor: 14.307

View more
  31 in total

Review 1.  Adeno-associated virus vectors and hematology.

Authors:  D W Russell; M A Kay
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

2.  Adeno-associated viruses undergo substantial evolution in primates during natural infections.

Authors:  Guangping Gao; Mauricio R Alvira; Suryanarayan Somanathan; You Lu; Luk H Vandenberghe; John J Rux; Roberto Calcedo; Julio Sanmiguel; Zahra Abbas; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

3.  Adeno-associated virus in adenovirus type 3 conjunctivitis.

Authors:  O W Schmidt; M K Cooney; H M Foy
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

4.  Twinned crystals of adeno-associated virus serotype 3b prove suitable for structural studies.

Authors:  Thomas F Lerch; Qing Xie; Heather M Ongley; Joan Hare; Michael S Chapman
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-01-31

5.  Crystallization and preliminary X-ray structural studies of adeno-associated virus serotype 6.

Authors:  Qing Xie; Heather M Ongley; Joan Hare; Michael S Chapman
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-10-31

6.  Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors.

Authors:  D D Koeberl; I E Alexander; C L Halbert; D W Russell; A D Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

7.  Good manufacturing practice production of self-complementary serotype 8 adeno-associated viral vector for a hemophilia B clinical trial.

Authors:  James A Allay; Susan Sleep; Scott Long; David M Tillman; Rob Clark; Gael Carney; Paolo Fagone; Jenny H McIntosh; Arthur W Nienhuis; Andrew M Davidoff; Amit C Nathwani; John T Gray
Journal:  Hum Gene Ther       Date:  2011-05       Impact factor: 5.695

8.  Comparative transduction efficiency of AAV vector serotypes 1-6 in the substantia nigra and striatum of the primate brain.

Authors:  Eleni A Markakis; Kenneth P Vives; Jeremy Bober; Stefan Leichtle; Csaba Leranth; Jeff Beecham; John D Elsworth; Robert H Roth; R Jude Samulski; D Eugene Redmond
Journal:  Mol Ther       Date:  2009-12-15       Impact factor: 11.454

9.  A new potent hFIX plasmid for hemophilia B gene therapy.

Authors:  Jeoung Soo Lee; Minhyung Lee; Sung Wan Kim
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

10.  Herpes simplex virus type 1/adeno-associated virus hybrid vectors.

Authors:  Anna Paula de Oliveira; Cornel Fraefel
Journal:  Open Virol J       Date:  2010-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.